Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1033 studies found for:    Open Studies | "Diabetes Mellitus, Type 2"
Show Display Options
Rank Status Study
21 Recruiting Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Diabetes Mellitus, Type 2;   Hypertriglyceridemia
Interventions: Drug: Fenofibrate;   Drug: Simvastatin
22 Recruiting Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
23 Recruiting 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin;   Drug: Acarbose
24 Recruiting A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg;   Drug: Canagliflozin 50 mg;   Drug: Canagliflozin 300 mg;   Drug: Placebo
25 Recruiting The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Conditions: Diabetes Mellitus, Type 2;   Diabetes
Interventions: Drug: Metformin;   Drug: Detemir;   Drug: Liraglutide;   Drug: Insulin Aspart
26 Recruiting A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
27 Not yet recruiting Stress Management Among Latinos With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: stress management
28 Unknown  Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
Conditions: Kidney Transplant;   Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Cyclosporin;   Drug: Tacrolimus;   Behavioral: Diabetes Education / Management
29 Recruiting Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Conditions: Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:
30 Unknown  The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Lipoic acid
31 Not yet recruiting GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Acarbose/Metformin (Glucobay M, BAY81-9783)
32 Not yet recruiting Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Matching albiglutide placebo
33 Not yet recruiting Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Insulin Glargine and Insulin Lispro
34 Recruiting A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Albuminuria
Interventions: Drug: Placebo;   Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg
35 Unknown  Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Other: multidisciplinary approach;   Other: multifactorial approach - for enhanced care group;   Other: reflects current patterns of care
36 Unknown  Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2
Condition: Diabetes Mellitus Type 2
Interventions: Procedure: GLP receptors expression;   Procedure: ESOPHAGOGASTRODUODENOSCOPY
37 Recruiting Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel
Condition: Diabetes Mellitus Type II
Intervention: Other: NONE intervention
38 Recruiting A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Dulaglutide;   Drug: Placebo;   Drug: Insulin Glargine;   Drug: Metformin
39 Unknown  Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes
Condition: Type II Diabetes
Intervention:
40 Recruiting Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin;   Drug: Insulin;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years